Cancer Gene (BRCA1) Malignancy: Its Not IN The Genes, So Much As WHAT You
Expose Them To
Written By: Sayer Ji
on the heels of Angelina
Jolie's widely celebrated decision to remove her breasts 'preventively,'
few folks truly understand how important preventing environmental chemical
exposures and incorporating cancer-preventing foods into their diet really
is in reducing the risk of gene-mediated breast cancer.
is so much fear and misinformation surrounding the so-called 'Breast Cancer
Associated' genes, BRCA1 and BRCA2, that it should help to dispel some prevailing
myths by looking at the crucial role that epigenetic factors play in their
expression. Literally 'above' (epi) or 'beyond' the control of the genes,
these factors include environmental chemical exposures, nutrition and stress,
which profoundly affect cancer risk within us all, regardless of what variant
('mutated' or 'wild')* that we happen to carry within our genomes.
a very important study was published in the Journal of Nutritional Biochemistry
that looked at the role a natural compound called resveratrol may play in
preventing the inactivation of the BRCA-1 gene. BRCA-1 is known as a "caretaker"
gene because it is responsible for healing up double-strand breaks within
our DNA. When the BRCA-1 gene is rendered dysfunctional or becomes inactivated,
either through a congenital/germline inheritance of DNA defects ('mutation')
or through chemical exposures, the result is the same: harm to the DNA repair
mechanisms within the affected cells (particularly breast and ovary; possibly
testicular), hence increasing the risk of cancer.
while the prevalence of a "bad" inherited BRCA1 variation is actually
quite low relative to the general population (A 2003 study found only 6.6%
of breast cancer patients even have either a BRCA1 and BRCA2 germline mutation),
everyone's BRCA1 and BRCA2 genes are susceptible to damage from environmental
chemical exposures, most particularly xenobiotic (non-natural) chemicals
and radiation. This means that instead of looking to a set of "bad"
genes as the primary cause of cancer, we should be looking to avoid exposing
both our "bad" and "good" genes alike to preventable
chemical exposures, as well as avoiding nutrient deficiencies and/or incompatibilities,
which also play a vital role in enabling us to express or silence cancer-associated
genes. [For more on why genes don't "cause" disease see: The
Great DNA Data Deficit.]
Natural Compound Prevents Breast Cancer Gene
aforementioned resveratrol study is titled "BRCA-1
promoter hypermethylation and silencing induced by the aromatic hydrocarbon
receptor-ligand TCDD are prevented by resveratrol in MCF-7 Cells."
the BRCA-1 promoter is the gene sequence within the BRCA1 gene that drives
the production of the protein that enables our cells to repair DNA damage,
and when "silenced" (i.e. hypermethylated) via the receptor for
aromatic hydrocarbons (which are primarily xenobiotic petrochemical compounds),
it leads to chromosomal damage within those cells. This study looked at
the role of resveratrol, a natural compound found in grapes, wine, chocolate,
and peanuts, in preventing these chemically-induced changes in gene methylation,
also known as 'gene silencing.'
to the study:
aberrant hypermethylation of tumor suppressor genes has been recognized
as a predisposing event in breast carcinogenesis . For example, BRCA-1
promoter hypermethylation has been linked to loss or silencing of BRCA-1
expression in sporadic breast tumors [2–7] and the development of
high-grade breast carcinomas [8–10]. Higher incidence (30%–90%)
of BRCA-1 hypermethylation has been reported in infiltrating tumors [2,10–12],
suggesting that epigenetic repression of BRCA-1 may accompany the transition
to more invasive phenotypes. Moreover, BRCA-1 promoter methylation was
found to be positively associated with increased mortality among women
with breast cancer .
researchers went on to test resveratrol's ability to prevent BRCA-promoter
inactivation caused by the persistent environmental pollutant 2,3,7,8 tetrachlorodibenzo-p-dioxin
(TCDD), which has been linked to birth defects, cancer, immune suppression,
liver damage and endocrine disruption, and has been found distributed throughout
the global food supply, and even in breast milk.
was found to prevent TCDD- induced suppression of BRCA-1 expression. They
discovered that resveratrol was capable of suppressed the silencing (hypermethylation)
of the BRCA-1 promoter, revealing one of several possible mechanisms for
anti-cancer properties, including 19 studies on GreenMedInfo.com alone
on its anti-breast cancer potential.
is only one of a wide range of natural, food-derived compounds which possess
the ability to bind and interact as ligands with the aromatic hydrocarbon
receptor (AhR) within the cells of our body. Curcumin, the primary polyphenol
in the spice turmeric, for instance, has been found to induce
programmed cell death in triple negative breast cancer cells, in part
through modulating BRCA1 protein expression and levels within the cytoplasm
of normal and cancerous cells.
researchers concluded "The fact that many food constituents possess
ligand properties towards the AhR [57,58] may offer new avenues for the
development of prevention strategies for the prevention of BRCA-1 silencing
in sporadic breast tumors."
is a fancy way of saying that we can prevent chemically-induced cancers
through including and perhaps increasing the level of phytoactive, chemopreventive
compounds within our diet; and of course, reducing and if possible eliminating
chemical exposures that 'knock out' the BRCA1/BRCA2 gene function in way
that leads to cancer. This, and not some gene-based future drug therapy,
is where researchers and medical practitioners should be 'racing' for their
long sought-after solution. Remove the cause. Prevent and cure the disease.
a list of 249 other natural substances that have experimentally confirmed
anti-breast cancer activity visit our Breast
Cancer research page, as well as our Health
Guide: Breast Cancer.
Silvia de Sanjosé, Mélanie Léoné, Victoria Bérez,
Angel Izquierdo, Rebeca Font, Joan M Brunet, Thierry Louat, Loreto Vilardell,
Joan Borras, Pau Viladiu, F Xavier Bosch, Gilbert M Lenoir, Olga M Sinilnikova.
of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a
population-based study. Int J Cancer. 2003 Sep 10 ;106(4):588-93. PMID:
Anti-Breast Cancer Properties (19 abstracts)
at the theoretical problems associated with BRCA1/BRCA2-mediated disease
causation in the article: Did
Angelina Jolie Make A Mistake By Acting On the Gene Theory of Breast Cancer